国企混改与公司内部治理结构研究——以东北制药为例  

Mixed Reform of State-owned Enterprises and Corporate Internal Governance Structure——Case Study of Northeast Pharmaceutical

作　　者：万立全 王玉琪 Wan Liquan;Wang Yuqi(School of economics and management,Shanghai Maritime University,Shanghai 201306)

机构地区：[1]上海海事大学经济管理学院,上海201306

出　　处：《北方经贸》2022年第6期138-141,共4页Northern Economy and Trade

摘　　要：通过对比东北制药混改前后公司内部治理结构,分析其公司内部治理结构改进情况。研究发现,混改后东北制药公司内部治理结构改进主要表现在三个方面:股权结构更加多元化,董事会成员构成更加合理化,高层员工激励得到改善。但是混改后,其公司内部治理结构还存在一些不足:普通员工缺乏激励措施;新选举的董事会成员缺乏经验。基于此,针对其不足之处提出相关建议。This paper compares the internal corporate governance of Northeast Pharmaceutical Group Co., Ltd.,before and after the introduction of private capital to state-owned enterprises during the mixed-ownership reform period, and finds that the internal corporate governance structure has been improved to a great extent, mainly in the following three aspects:The ownership structure is more diversified;The composition of the board of directors is more reasonable;The incentive of senior staff has been improved.However, it also has shortcomings: The lack of incentive measures for ordinary employees;Newly elected board members lack experience. Finally, this paper puts forward some suggestions for its shortcomings.

关 键 词：国企混改 公司内部治理结构 东北制药 

分 类 号：F276[经济管理—企业管理]